Theranos

Board of Directors

Donald L. Lucas, Chairman of the Board

Mr. Lucas is well-known as a founding partner of such companies as National Semiconductor Corporation, Macromedia, Inc., PDF Solutions, Inc., and Oracle Corporation. Mr. Lucas is currently on the board of Cadence Design Systems, Inc., Chairman of the Executive Committee of the Board of Directors of Oracle Corporation (Don served as Chairman from October 1980 to May 1990), Chairman of the Board of 51Job, and Chairman of the Board of Dexcom, Inc. In addition, Mr. Lucas serves as a Director for several other public and private companies. Mr. Lucas was a General and Limited Partner of Draper, Gaither & Anderson (DG&A), the first venture capital firm, before investing independently. Don Lucas received his Bachelor of Arts degree from Stanford University and his MBA from Stanford's Graduate School of Business.

Robert B. Shapiro

Mr. Shapiro is Chairman and Managing Director of Sandbox Industries, LLC, which funds, incubates and develops new businesses and manages venture investment funds. Previously, he was Chairman and Executive Officer of Monsanto Company, a position to which he was appointed in 1995 after sixteen years with the company and its predecessor, G.D. Searle & Co. where he was CEO of The Nutrasweet Company. Upon the merger of Monsanto with Pharmacia & Upjohn, he served as Chairman of the newly formed Pharmacia Corporation until his retirement in February 2001. Mr. Shapiro has served as a director of NYSE Euronext, Citigroup and Rockwell International.

Peter Thomas

Mr. Thomas is a co-founder and Managing Director of ATA Ventures. Pete comes to ATA Ventures having enjoyed a highly successful career in venture capital activities across the past 20 years. In 1985, he joined Institutional Venture Partners (IVP) as a General Partner in their IVP III fund and continued as a General Partner of IVP through the IVP III-VIII funds. Companies that Pete has successfully led investments in include Nellcor, Applied Medical, Atmel (ATML), Altera (ALTR), @Road (ARDI), Transmeta (TMTA), Cirrus Logic (CRUS), Form Factor (FORM), and many others. Pete serves on the board of several other private companies. Prior to venture capital activities, Pete was at Intel Corporation for 7 years in various engineering and marketing management roles. Pete graduated magna cum laude in 1968 with a BSEE degree from Utah State University and received his MS in Computer Science from the University of Santa Clara in 1975.

Channing Robertson

Dr. Robertson is the Ruth G. and William K. Bowes Professor in the School of Engineering, Stanford University. He has been a member of the faculty of the Chemical Engineering Department for forty years, having served two terms as Chair. He recently completed a six year appointment as Senior Associate Dean of the School of Engineering. Dr. Robertson has spent much of his career designing and developing advanced drug delivery systems for therapeutic applications. In addition he has published widely in the area of biotechnology with an emphasis on compact bioreactor design, two-dimensional protein crystallization and solid phase substrate enzyme catalysis. He worked with architect Norman Foster in designing the James H. Clark Center at Stanford, a facility that continues to attract global attention in providing an interdisciplinary platform for collaboration among engineering, and the medical, physical and life sciences. Channing served as an expert witness in several trials including the Copper-7 intrauterine contraceptive cases (in the U.S. and Australia), the Stringfellow Superfund case and the Minnesota tobacco case where he provided testimony on tobacco material processing, cigarette design and manufacturing, and nicotine delivery systems. He is a Founding Fellow, American Institute of Medical and Biological Engineering, a Member of the Science, Law and Technology Law Program Committee of the National Academy of Sciences, and the Panel on Court Appointed Scientific Experts (CASE) of the American Association for the Advancement of Science. Channing co-authored the recent congressional National Academy of Sciences report on "Strengthening Forensic Science in the United States: A Path Forward". He was lead author on the "Reference Guide on Engineering" as part of the revision of the Federal Reference Manual on Scientific Evidence used by all Federal and most State Court judges. It was commissioned by the Federal Judicial Center and the National Academy of Sciences. Channing was selected by the Director General, World Health Organization, to help prepare the Framework Convention Treaty on Tobacco Control, the first treaty negotiated under the auspices of WHO. It is now in force and signed by more than 160 countries. He received his BS (with Honors) in Chemical Engineering from the University of California at Berkeley and received his MS & PhD degrees in Chemical Engineering in fluid mechanics and transport phenomena from Stanford University. He was featured in Upside Magazine's special issue on "100 People Who Have Changed the World". Channing is an instrument-rated pilot [land and sea] and is an avid backpacker and fly fisherman.